Ionlace

Ionlace

Biotech and materials R&D with commercialization

Overview

Company Does Not Provide H1B Sponsorship

IONLACE is a biotech-focused R&D company that builds and funds science projects in biotechnology, molecular biology, and advanced materials. It hires highly skilled, highly curious scientists—“rebel scientists”—and gives them resources and freedom to pursue ambitious, real-world-impact ideas. The company operates in innovation hubs like Stockholm and Copenhagen to accelerate research and development. Revenue comes from advancing R&D projects toward commercialization through patents, partnerships with larger companies, and market-ready products, as well as grants and venture funding. IONLACE differentiates itself by prioritizing rapid execution and bold, high-risk research led by top talent, aiming to stay ahead in a competitive field. Its goal is to shape the future of scientific and technological progress by turning breakthroughs into practical applications through collaborations, licensing, and new products.

Significant Headcount Growth

About Ionlace

Simplify's Rating
Why Ionlace is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Venture Capital

Industrial & Manufacturing

Biotechnology

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Solna kommun, Sweden

Founded

2023

Get referred to Ionlace

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • LinkedIn showed multiple hiring posts in Stockholm through 2025, signaling active execution.
  • BIO 2025 listed IONLACE with an advanced AI fusion protein platform.
  • BuiltIn listed only 10 employees in 2026, leaving room for fast upside from small wins.

What critics are saying

  • Tracxn says IONLACE raised no funding rounds by 2025, limiting runway.
  • A platform-only model faces dilution if ACME and other investors never materialize.
  • If protein-engineering results stall in 2026, IONLACE becomes a hiring story, not a company.

What makes Ionlace unique

  • IONLACE claims an AI-enabled fusion protein platform, validated by Karolinska lab work in 2025.
  • Its Stockholm-Karlslkrona? no, Stockholm-Copenhagen footprint concentrates talent in Nordic biotech hubs.
  • The company targets modular, plug-and-play biologics engineering, not a single therapeutic program.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Paid Vacation

401(k) Retirement Plan

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Ionlace right now.

Find jobs on Simplify and start your career today

We update Ionlace's jobs every few hours, so check again soon! Browse all jobs →